3918PCI Holdings

3293AZUMA HOUSE

3097The Monogatari Corporation

2384SBS Holdings

3652Digital Media Professionals

3196HOTLAND

6750ELECOM

3401Teijin

3393Startia Holdings

2404TETSUJIN

4387ZUU

7084Kids Smile Holdings

8918LAND

3277Sansei Landic

9857EIWA

6912KIKUSUI ELECTRONICS

3808OKWAVE

2492Infomart

9787AEON DELIGHT

4662Focus Systems

9531TOKYO GAS

4012AXIS

6294OKADA AIYON

4445Living Technologies

2749JP-HOLDINGS

2352WOW WORLD

5805SWCC SHOWA HOLDINGS

6656inspec

3490Azplanning

4985Earth Corporation

6676MELCO HOLDINGS

7339ipet Holdings

3849NIPPON TECHNO LAB

5933ALINCO

3559p-ban.com

3030HUB

3950THE PACK

7640TOP CULTURE

7810Crossfor

4699UCHIDA ESCO

8938GLOME Holdings

6890Ferrotec Holdings

6073ASANTE

3294e'grand

6867LEADER ELECTRONICS

7590TAKASHO

9517eREX

6835Allied Telesis HD

6175Net Marketing

3237INTRANCE

2154BeNext-Yumeshin Group

4572Carna Biosciences

6547GREENS

6640I-PEX

1904TAISEI ONCHO

4379Photosynth

7463ADVAN GROUP

3392DELICA FOODS HOLDINGS

4674CRESCO

2767FIELDS

1430First-corporation

9904Verite

3387create restaurants holdings

7780Menicon

1431Lib Work

8737Akatsuki Corp

3435SANKO TECHNO

3837Ad-Sol Nissin

4760ALPHA

3916Digital Information Technologies

2311EPCO

6625JALCO Holdings

7343Broad-Minded

4286CL Holdings

4171Global Information

5070DRAFT

2735WATTS

4293SEPTENI HOLDINGS

6460SEGA SAMMY HOLDINGS

6240YAMASHIN-FILTER

9997BELLUNA

7771Nihon Seimitsu

6157NS TOOL

2586FRUTA FRUTA

2488JTP

4563AnGes

8940INTELLEX

4018Geolocation Technology

3968Segue Group

3276Japan Property Management Center

6837KYOSHA

8920TOSHO

5992CHUO SPRING

5011NICHIREKI

4745Tokyo Individualized Educational Institute

4381BPLATS

7438KONDOTEC

7637Hakudo

4284SOLXYZ

2702Mcdonald's Holdings(Japan)

6879IMAGICA GROUP

4310Dream Incubator

3113Oak Capital

8179Royal Holdings

4304Estore

9740CENTRAL SECURITY PATROLS

8925ARDEPRO

3753FLIGHT HOLDINGS

3918PCI Holdings

3293AZUMA HOUSE

3097The Monogatari Corporation

2384SBS Holdings

3652Digital Media Professionals

3196HOTLAND

6750ELECOM

3401Teijin

3393Startia Holdings

2404TETSUJIN

4387ZUU

7084Kids Smile Holdings

8918LAND

3277Sansei Landic

9857EIWA

6912KIKUSUI ELECTRONICS

3808OKWAVE

2492Infomart

9787AEON DELIGHT

4662Focus Systems

9531TOKYO GAS

4012AXIS

6294OKADA AIYON

4445Living Technologies

2749JP-HOLDINGS

2352WOW WORLD

5805SWCC SHOWA HOLDINGS

6656inspec

3490Azplanning

4985Earth Corporation

6676MELCO HOLDINGS

7339ipet Holdings

3849NIPPON TECHNO LAB

5933ALINCO

3559p-ban.com

3030HUB

3950THE PACK

7640TOP CULTURE

7810Crossfor

4699UCHIDA ESCO

8938GLOME Holdings

6890Ferrotec Holdings

6073ASANTE

3294e'grand

6867LEADER ELECTRONICS

7590TAKASHO

9517eREX

6835Allied Telesis HD

6175Net Marketing

3237INTRANCE

2154BeNext-Yumeshin Group

4572Carna Biosciences

6547GREENS

6640I-PEX

1904TAISEI ONCHO

4379Photosynth

7463ADVAN GROUP

3392DELICA FOODS HOLDINGS

4674CRESCO

2767FIELDS

1430First-corporation

9904Verite

3387create restaurants holdings

7780Menicon

1431Lib Work

8737Akatsuki Corp

3435SANKO TECHNO

3837Ad-Sol Nissin

4760ALPHA

3916Digital Information Technologies

2311EPCO

6625JALCO Holdings

7343Broad-Minded

4286CL Holdings

4171Global Information

5070DRAFT

2735WATTS

4293SEPTENI HOLDINGS

6460SEGA SAMMY HOLDINGS

6240YAMASHIN-FILTER

9997BELLUNA

7771Nihon Seimitsu

6157NS TOOL

2586FRUTA FRUTA

2488JTP

4563AnGes

8940INTELLEX

4018Geolocation Technology

3968Segue Group

3276Japan Property Management Center

6837KYOSHA

8920TOSHO

5992CHUO SPRING

5011NICHIREKI

4745Tokyo Individualized Educational Institute

4381BPLATS

7438KONDOTEC

7637Hakudo

4284SOLXYZ

2702Mcdonald's Holdings(Japan)

6879IMAGICA GROUP

4310Dream Incubator

3113Oak Capital

8179Royal Holdings

4304Estore

9740CENTRAL SECURITY PATROLS

8925ARDEPRO

3753FLIGHT HOLDINGS

What's New
New Analyst Reports
Information

What's New

  • 01/20/2022NEW
  • inspec(6656)
  • Financial Results for Q2 of the Fiscal Year Ending April 2022
  • AnGes(4563)
  • Analyst report(Shared Research): Commenced Phase IIa study of AV-001 in patients with severe COVID-19
  • 01/19/2022NEW
  • JP-HOLDINGS(2749)
  • [Delayed]Announcement of Transition to "Prime Market" in New Market Segment
  • Segue Group(3968)
  • [Delayed]Plan for Compliance with the Listing Maintenance Criteria for the New Market Segment
  • AnGes(4563)
  • Vasomune and AnGes Announce First Patient Enrolled in Phase 2a Clinical Study Evaluating AV-001 for the Treatment of Severe COVID-19 Disease
  • 01/18/2022NEW
  • TOP CULTURE(7640)
  • Financial Results for FY10/21
  • CRESCO(4674)
  • [Delayed] Notice Concerning New Market Segment Selection Results Announced by the Tokyo Stock Exchange
  • 01/17/2022
  • WATTS(2735)
  • Summary of Financial Results for the First Quarter Ended November 30, 2021 [Japan GAAP] (Consolidated)
  • 01/14/2022
  • create restaurants holdings(3387)
  • Summary of Business Results for the Third Quarter Ended November 30, 2021 [IFRS] (Consolidated)
  • SOLXYZ(4284)
  • FY12/21 3Q Presentation Materials for Institutional Investors
  • WATTS(2735)
  • Notice Regarding December 2021 Monthly YoY Change in Sales and Number of Shops
  • 01/13/2022
  • Azplanning(3490)
  • Summary of Business Results for the Third Quarter Ended November 30, 2021 [Japan GAAP] (Non-consolidated)
  • HUB(3030)
  • Summary of Business Results for the Third Quarter Ended November 30, 2021 [Japan GAAP] (Non-consolidated)
  • LAND(8918)
  • Summary of Business Results for the Third Quarter Ended November 30, 2021 [Japan GAAP] (Consolidated)
  • INTELLEX(8940)
  • Summary of Business Results for the Second Quarter Ended November 30, 2021 [Japan GAAP] (Consolidated)
  • ASANTE(6073)
  • December Monthly Sales Report for FY Ending March 2022
  • The Monogatari Corporation(3097)
  • Notice Regarding December 2021 Preliminary Monthly YoY Change in Sales and Number of Restaurants
  • Verite(9904)
  • December 2021 Flash Report vs. LY
  • AEON DELIGHT(9787)
  • Analyst report(Shared Research) : Released Q3 FY02/22 results
  • 01/12/2022
  • Net Marketing(6175)
  • Analyst report(Shared Research) : Interview following the Announcement of Financial Results for Q1 FY06/22 [Report Update]
  • CENTRAL SECURITY PATROLS(9740)
  • Summary of Business Results for the Third Quarter Ended November 30, 2021 [Japan GAAP] (Consolidated)
  • ALPHA(4760)
  • Summary of Financial Results for the First Quarter Ended November 30, 2021 [Japan GAAP] (Consolidated)
  • AEON DELIGHT(9787)
  • Supplementary Information on the Financial Results for the Nine Months Ended November 30, 2021
  • Summary of Financial Results for the Third Quarter Ended November 30, 2021 [Japan GAAP] (Consolidated)
  • ADVAN GROUP(7463)
  • Summary of Business Results for the Third Quarter Ended December 31, 2021 [Japan GAAP] (Consolidated)
  • Net Marketing(6175)
  • December 2021 Monthly IR News
  • Analyst report(Shared Research) : Monthly investor relations news for December 2021
  • 01/11/2022
  • Earth Corporation(4985)
  • Notice Concerning the Transition to the Prime Market in Tokyo Stock Exchange New Market Segment
  • Ferrotec Holdings(6890)
  • Q&A Summary of the Online Explanatory Session for Analysts and Institutional Investors for the Second Quarter of the Fiscal Year Ending March 31, 2022
  • (Change of a Disclosed Item) Notice of the Conclusion of an Advisory Contract for Listing Between the Subsidiary that Manufactures Components for Semiconductor Manufacturing (Quartz Crucibles and Silicon Parts) and Everbright Securities (the Lead-managing Securities Firm) and the Approval for Registration by the China Securities Regulatory Commission
  • Progress on the Mid-Term Management Plan (FY3/22-FY3/24)
  • Results for the 1st half of the fiscal year ending March 31, 2022
  • Tokyo Individualized Educational Institute(4745)
  • Summary of Business Results for the Third Quarter Ended November 30, 2021 [Japan GAAP] (Consolidated)
  • IMAGICA GROUP(6879)
  • Q&A sessions at financial results briefings and small meetings (summary)
  • Menicon(7780)
  • Daily Disposable Lens "1DAY Menicon PremiO multifocal" Launch in Japan
  • First-corporation(1430)
  • Summary of Financial Results for the second quarter of the fiscal year Ending May 31, 2022 <Japan GAAP> (non-consolidated)
  • SEGA SAMMY HOLDINGS(6460)
  • SUSTAINABILITY ACTION REPORT 2021
  • INTEGRATED REPORT 2021 (1/3)
  • INTEGRATED REPORT 2021 (2/3)
  • INTEGRATED REPORT 2021 (3/3)
  • 01/08/2022
  • KONDOTEC(7438)
  • KONDOTEC REPORT(Year Ended March 31, 2021)
  • 01/07/2022
  • ZUU(4387)
  • Financial Results for 2Q of FY3/22
  • 01/06/2022
  • Mcdonald's Holdings(Japan)(2702)
  • Monthly IR News
  • SANKO TECHNO(3435)
  • [ IR STREET REPORT ]: Japan's leading post-installation anchor manufacturer. An attractive value stock with stable earnings and dividends!
  • Broad-Minded(7343)
  • [ IR STREET REPORT ]: Financial partner company growing with its one-stop financial consulting services for a wide range of generations!
  • FIELDS(2767)
  • Launch of New Pachislot Machine "BLACK LAGOON ZERO bullet MAX"
  • 01/05/2022
  • KONDOTEC(7438)
  • Analyst report(Shared Research) : Interview following the Announcement of Financial Results for Q2 FY03/22 [Report Update]
  • Carna Biosciences(4572)
  • Submission of Investigational New Drug Application for AS-1763 (BN102) in China by BioNova
  • CRESCO(4674)
  • [Delayed] Notice Concerning Changes of Executive Officers
  • SEGA SAMMY HOLDINGS(6460)
  • Notice Regarding the Status of Acquisition of Treasury Stocks
  • TOP CULTURE(7640)
  • FY10/2022 Preliminary sales figures (December)
  • 01/04/2022
  • SEPTENI HOLDINGS(4293)
  • Notice of Change in Major Shareholders
  • Notice of: Effectiveness of Share Exchange with Dentsu Direct Inc. etc.
  • 12/29/2021
  • Segue Group(3968)
  • Notice Concerning Status of Acquisition of Treasury Stock (Acquisition of Treasury Stock stipulated in the Articles of Incorporation pursuant to Article 165-2 of the Corporate Law)
  • Notice of Resolution Regarding Acquisition of Treasury Stock (Acquisition of Treasury Stock stipulated in the Articles of Incorporation pursuant to Article 165-2 of the Corporate Law)
  • Notice of Revision to Consolidated Business Forecasts
  • Carna Biosciences(4572)
  • Carna Announces Initiation of MAD study of Phase 1 Clinical Study for AS-0871
  • 12/28/2021
  • AXIS(4012)
  • Notice of Revision to Full-year Business Forecasts
  • JP-HOLDINGS(2749)
  • [Delayed]Presentation Material of Financial Results for the 2nd Quarter of Fiscal Year ending March 2022
  • NICHIREKI(5011)
  • Financial Results for the 2nd Quarter of FY3/22
  • SBS Holdings(2384)
  • Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q3 FY12/21 [Report Update]
  • 12/27/2021
  • Earth Corporation(4985)
  • Analyst report(Shared Research) : Interview following the Announcement of Financial Results for Q3 FY12/21 [Report Update]
  • Menicon(7780)
  • Corporate Governance Report
  • IMAGICA GROUP(6879)
  • [Delayed] Notice of Revisions to Financial Forecast and Dividend Forecast(Dividend Increase)
  • Ferrotec Holdings(6890)
  • Notice Concerning Determination of the Number of New Shares to be Issued by way of Third-Party Allotment
  • 12/24/2021
  • Teijin(3401)
  • Corporate Governance Report
  • JALCO Holdings(6625)
  • Financial Results for Q2 FY3/22
  • 12/23/2021
  • Teijin(3401)
  • Notice Regarding Change in Representative Directors
  • SEPTENI HOLDINGS(4293)
  • Corporate Governance Report
  • Carna Biosciences(4572)
  • Revision of Results Forecast for the Fiscal Year Ending December 31, 2021
  • Carna Receives First Milestone Payment from Gilead
  • 12/22/2021
  • create restaurants holdings(3387)
  • [Delayed] Notice of Application for Selection of the Prime Market in New Market Segments
  • 12/21/2021
  • Carna Biosciences(4572)
  • Carna Announces to Extend the Agreement with Sumitomo Dainippon Pharma on Joint Research, Development, and Commercialization of Kinase Inhibitors
  • Ferrotec Holdings(6890)
  • Notice of the Investment in a Project for Semiconductors by our Chinese Subsidiaries
  • CRESCO(4674)
  • [Delayed] Notice Concerning Completion of Payment for Disposal of Treasury Shares as Restricted Shares Remuneration for Employees of the Company
  • New Analyst Reports

    1/19 AnGes, Inc.(4563) Analyst report(Shared Research): Commenced Phase IIa study of AV-001 in patients with severe COVID-19
    1/12 AEON DELIGHT CO.,LTD.(9787) Analyst report(Shared Research) : Released Q3 FY02/22 results
    1/12 Net Marketing Co. Ltd.(6175) Analyst report(Shared Research) : Interview following the Announcement of Financial Results for Q1 FY06/22 [Report Update]
    1/5 IMAGICA GROUP Inc.(6879) Q&A sessions at financial results briefings and small meetings (summary)
    1/5 KONDOTEC INC.(7438) Analyst report(Shared Research) : Interview following the Announcement of Financial Results for Q2 FY03/22 [Report Update]
    (2021)
    12/28
    SBS Holdings,Inc(2384) Analyst Report(Shared Research) : Interview following the Announcement of Financial Results for Q3 FY12/21 [Report Update]
    (2021)
    12/24
    Earth Corporation(4985) Analyst report(Shared Research) : Interview following the Announcement of Financial Results for Q3 FY12/21 [Report Update]
    (2021)
    12/17
    ipet Holdings,Inc.(7339) Analyst Report(Shared Research): Interview following the Announcement of Financial Results for Q2 FY03/22 [Report Update]
    (2021)
    12/3
    Infomart Corporation(2492) Analyst report(Shared Research) : Interview following the Announcement of Financial Results for Q3 FY12/21 [Report Update]
    (2021)
    11/30
    SANKO TECHNO CO.,LTD.(3435) [ IR STREET REPORT ]: Japan's leading post-installation anchor manufacturer. An attractive value stock with stable earnings and dividends!
    (2021)
    11/26
    Broad-Minded Co.,Ltd.(7343) [ IR STREET REPORT ]: Financial partner company growing with its one-stop financial consulting services for a wide range of generations!
    (2021)
    11/25
    NS TOOL CO.,LTD.(6157) Analyst report(Shared Research): Interview following the Announcement of Financial Results for Q2 FY03/22 [Report Update]
    (2021)
    11/15
    Estore Corporation(4304) Analyst Report (Shared Research) : Released Q2 FY03/22 results
    (2021)
    11/10
    Dream Incubator Inc.(4310) Analyst Report(Shared Research) : Released Q2 FY03/22 results

    Information

    Information

       12/29   What's new: CHUO SPRING CO.,LTD.(5992)


       12/24   Earnings Calendar has been updated.



    Newly Added Company

    Date:12/29
    CHUO SPRING(5992:TSE1)

    Date:11/5
    Photosynth(4379:MTH)

    Latest Video & Presentations

    Latest Video&Slides

    Company news
    provided by Timely Disclosure Network

    News Release

    Stock Code or Name:

    4552   JCR Pharmaceuticals Co.,Ltd.

    11/30/2021 16:00 Notice of Personnel Changes
    11/25/2021 17:00 Notice Regarding Change in Major Shareholders
    11/18/2021 16:30 Notice Regarding Hyogo Work-life Balance Company Award
    11/12/2021 16:00 [Delayed] Consolidated Financial Results for the Six Months ended September 30, 2021(FY2021)
    11/02/2021 15:00 [Delayed] Distribution of Retained Earnings (Increase in Interim Dividend) and Revision of Year-End Dividend Forecast (Increase in Dividend)
    10/18/2021 16:00 EMA grants PRIME Designation for JR-141 for the treatment of Mucopolysaccharidosis Type II (Hunter Syndrome)
    10/15/2021 16:30 JR-141 for Hunter Syndrome Notice on the Publication of a nonclinical and clinical evidence in Internal Journal of Molecular Sciences
    10/05/2021 16:00 US FDA grants Fast Track Designation for JR-171 for the Treatment of Mucopolysaccaridosis Type I (MPSI)
    09/30/2021 17:00 Takeda to Commercialize Next-Generation Hunter Syndrome Therapy Through Collaboration with JCR Pharmaceuticals
    09/30/2021 17:00 JCR Announces to have Revised the Consolidated Financial Forecast
    09/16/2021 14:30 [Delayed] Financial Summary Consolidated Financial Results for the Year ended June 30, 2021 (FY2021) (Japanese Standard)
    07/29/2021 16:00 JR-141 for Hunter Syndrome Notice on the Publication of a case report in Japan in JIMD reports
    07/29/2021 16:00 JCR Announces Presentations at the MPS2021
    07/14/2021 16:00 Notice regarding Finalized Details of issuance of Stock Options as Stock-linked Compensation (Share Subscription Rights)
    06/25/2021 15:00 [Delayed] Financial Summary Consolidated Financial Results for the Year ended March 31, 2021 (FY2020) (Japanese standard)
    06/23/2021 16:00 Matters Concerning Controlling Shareholders (Affiliated Companies)
    06/23/2021 16:00 Notice of Allotment of Stock Options as Stock-linked Compensation (Share Subscription Rights)
    06/18/2021 08:00 Notice of Convocation of the 46th Ordinary General Meeting of Shareholders
    05/24/2021 16:00 [Delayed]Notice of Issuance of Stock Options as Stock-linked Compensation (Share Subscription Rights)
    05/19/2021 08:30 Launch of IZCARGO I.V. Infusion 10mg (JR-141: Pabinafusp Alfa) for Treatment of MPS II (Hunter Syndrome) in Japan
    05/18/2021 16:00 JCR Announces First Patient Dosed in Ph2 Clinical Trial of JR-142, A long-acting growth hormone
    05/13/2021 16:00 Notice of Distribution of Retained Earnings
    04/27/2021 16:00 Notice Regarding Change of Directors and Nomination of Candidates for New Members of the Board of Directors
    04/27/2021 16:00 Notice on Change of Representative Directors
    04/27/2021 16:00 Notice of Organizational and Personnel Changes
    04/20/2021 16:00 JR-141 for Hunter Syndrome Notice on the Publication of the Results of Non-Clinical Trials in Molecular Genetics and Metabolism Reports
    03/30/2021 16:00 EMA grants Orphan Drug Designation to JR-171 for the Treatment of MPS I
    03/29/2021 16:00 JR-141 for Hunter Syndrome Notice on the Publication of the Results of the Ph2 Clinical Trial in Brazil in Molecular Therapy
    03/25/2021 16:00 JCR Announces to have Revised the Consolidated Financial Forecast
    03/23/2021 15:00 JCR Pharmaceuticals Announces Approval of IZCARGO for Treatment ot MPS II in Japan
    03/08/2021 17:00 JCR Announces Discontinuation of Development of JR-031EB, Expanded Indication of TEMCELL HS Inj. for Epidermolysis Bullosa
    03/04/2021 14:00 Notice of Construction of New Plant for COVID-19 Vaccine Solution
    02/25/2021 16:00 Notice of Organizational and Personnel Changes
    02/16/2021 10:00 JCR Presents Research at WORLDSymposium2021 Showing Potential Benefits of JR-141 in Patients with MPS II
    02/12/2021 16:00 US FDA grants Orphan Drug Designation to JR-171 for the Treatment of Mucopolysaccaridosis Type I (MPS I)
    02/10/2021 16:30 FDA grants Fast Track Designation for JR-141 for the treatment of MPS II (Hunter Syndrome)
    02/10/2021 16:30 JCR Receives FDA IND Clearance Initiate Global Ph3 Clinical Trial of JR-141 for MPS II (Hunter Syndrome)
    02/04/2021 16:30 JCR to Present at the 17th Annual WORLDSymposium2021
    01/27/2021 16:30 JR-141 for Hunter syndrome Notice on the Publication of the Results of non-clinical Tirals in Molecular Therapy